Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Group14 Technologies manufactures and supplies advanced silicon-carbon composite anode materials for lithium-silicon batteries. Their flagship product SCC55 enables higher energy density and rapid charging/discharging for applications in electric vehicles, consumer electronics, and energy storage. The company has commercial partnerships with major OEMs such as Porsche and Amperex Technology Limited. No clinical results as it does not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Group14 Technologies.